Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 131, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2019.104567
Keywords
P2Y(14) receptor; Trigeminal ganglion; Complete Preund's adjuvant; Cytokines; Mitogen-activated protein kinases
Categories
Funding
- Department of Science and Technology of Sichuan Province [2015JY0146]
- National Natural Science Foundation of China [81870800]
Ask authors/readers for more resources
P2Y purinergic receptors expressed in neurons and satellite glial cells (SGCs) of the trigeminal ganglion (TG) contribute to inflammatory and neuropathic pain. P2Y(14) receptor expression is reported in the spinal cord, dorsal root ganglion (DRG), and TG. In present study, the role of P2Y(14) receptor in the TG in inflammatory orofacial pain of Sprague-Dawley (SD) rats was investigated. Peripheral injection of complete Freund's adjuvant (CFA) induced mechanical hyperalgesia with the rapid upregulation of P2Y(14) receptor, glial fibrillary acidic protein (GFAP), interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), C-C chemokine CCL2, phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2), and phosphorylated p38 (p-p38) proteins in the TG. Furthermore, immunofluorescence staining confirmed the CFA-induced upregulation of P2Y(14) receptor. Double immunostaining showed that P2Y(14) receptor colocalized with glutamine synthetase (GS) and neuronal nuclei (NeuN). Finally, trigeminal injection of a selective antagonist (PPTN) of P2Y(14) receptor attenuated CFA-induced mechanical hyperalgesia. PPTN also decreased the upregulation of the GFAP, IL-1 beta, TNF-alpha, CCL2, p-ERK1/2, and p-p38 proteins. Our findings showed that P2Y(14) receptor in TG may contribute to orofacial inflammatory pain via regulating SGCs activation, releasing cytokines (IL-1 beta, TNF-alpha, and CCL2), and phosphorylating ERK1/2 and p38.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available